Research graph
References from Seasonal and Age-Stratified Patterns of Influenza, COVID-19, and RSV in Poland (2024–2026). Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Global, Regional, and National Burden of Lower Respiratory Infections in Children: A Systematic Analysis for the Global Burden of Disease Study, 2021
10.1111/ppe.70064 · 2025 · External reference
Excess Mortality and Hospitalisations Associated with Respiratory Syncytial Virus, Influenza, and COVID-19 among Adults in Denmark (2015–2024): A Modelling Study
10.1016/j.lanepe.2025.101396 · 2025 · External reference
A Comparative Review on the Epidemiology of Influenza, COVID-19 and Respiratory Syncytial Viruses
10.1007/s44337-025-00518-z · 2025 · External reference
The Morbidity Spectrum of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Human Parainfluenza Virus in Young Children by Age and Country Income Level: A Systematic Review and Meta-Analysis
10.1016/j.ijid.2025.107938 · 2025 · External reference
Clinical Features and Outcomes of Viral Respiratory Infections in Adults during the 2023–2024 Winter Season
10.1038/s41598-025-19236-8 · 2025 · External reference
10.3390/vaccines13121234
10.3390/vaccines13121234 · External reference
High Clinical Burden of Influenza Disease in Adults Aged ≥65 Years: Can We Do Better? A Systematic Literature Review
10.1007/s12325-023-02432-1 · 2023 · External reference
Influenza Virus: Dealing with a Drifting and Shifting Pathogen
10.1089/vim.2017.0141 · 2018 · External reference
Antigenic Drift and Antivaccine Shift in the 2025–2026 Influenza Season
10.1056/nejmp2600395 · 2026 · External reference
Tracking Clinical Severity of Influenza in Adult Hospitalized Patients in 2024: Data from the FluTer Registry in Poland
10.1016/j.vaccine.2025.127443 · 2025 · External reference
How Has the COVID-19 Pandemic Affected the Influenza Seasonality Patterns in Different Climate Regions?—A Time-Series Analysis
10.1002/hsr2.71456 · 2026 · External reference
Global Analysis of Influenza Epidemic Characteristics in the First Two Seasons after Lifting the Nonpharmaceutical Interventions for COVID-19
10.1016/j.ijid.2024.107372 · 2025 · External reference
High Seroprevalence and High Risk: Why Are Older Adults More Prone to Respiratory Syncytial Virus?
10.1128/jvi.01432-25 · 2025 · External reference
10.3390/vaccines13070741
10.3390/vaccines13070741 · External reference
10.3390/vaccines13020159
10.3390/vaccines13020159 · External reference
Awareness of Respiratory Syncytial Virus and Other Respiratory Disease Vaccines among Healthcare Professionals and Their Patients in Italy: Insights from a Literature Review and a Web-Based Survey
10.1080/21645515.2025.2552557 · 2025 · External reference
Primary Care Physicians’ Perspectives on Respiratory Syncytial Virus (RSV) Disease in Adults and a Potential RSV Vaccine for Adults
10.1016/j.vaccine.2018.12.031 · 2019 · External reference
Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches
10.1002/jmv.71057 · 2026 · External reference
Outpatient RSV Testing Rates among US Adults with Lower Respiratory Tract Disease, 2017–2024
10.1007/s40121-026-01300-z · 2026 · External reference
Usefulness of RSV Rapid Diagnostic Tests in Hospitalised Children
10.15557/pimr.2024.0028 · 2024 · External reference
10.64898/2026.02.27.26347213
10.64898/2026.02.27.26347213 · External reference
SARS-CoV-2 Omicron Is an Immune Escape Variant with an Altered Cell Entry Pathway
10.1038/s41564-022-01143-7 · 2022 · External reference
The Virology of Omicron: Pathophysiology, Immune Regulation, and Clinical Impact of SARS-CoV-2 Sub Variants
10.1186/s12985-025-03020-1 · 2025 · External reference
Decoding Omicron: Genetic Insight into Its Transmission Dynamics, Severity Spectrum and Ever-Evolving Strategies of Immune Escape in Comparison with Other SARS-CoV-2 Variants
10.1016/j.diagmicrobio.2025.116705 · 2025 · External reference
Worldwide SARS-CoV-2 Omicron Variant Infection: Emerging Sub-Variants and Future Vaccination Perspectives
10.1016/j.jfma.2024.08.021 · 2024 · External reference
10.3390/jcm14175992
10.3390/jcm14175992 · External reference
Update on Omicron Variant and Its Threat to Vulnerable Populations
10.1016/j.puhip.2024.100494 · 2024 · External reference
Unresolved reference
External reference
10.3389/fpubh.2026.1885724
10.3389/fpubh.2026.1885724 · External reference
Unresolved reference
External reference
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain
10.3201/eid2710.211184 · 2021 · External reference
Short-Term and Long-Term Mortality Following Hospitalized and Ambulatory Lower Respiratory Tract Illnesses among US Adults
10.1093/ofid/ofaf186 · 2025 · External reference
10.1371/journal.ppat.1014169
10.1371/journal.ppat.1014169 · External reference
10.3389/fpubh.2025.1621873
10.3389/fpubh.2025.1621873 · External reference
10.3390/vaccines14080651
10.3390/vaccines14080651 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
The Impact of Vaccine Beliefs on the COVID-19 Vaccination among Polish Medical Staff and Students: A Cross-Sectional Study
10.1097/md.0000000000048421 · 2026 · External reference
Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-Analysis
10.1128/jcm.01816-15 · 2015 · External reference
Respiratory Viruses Transmission from Children to Adults within a Household
10.1016/j.vaccine.2011.11.047 · 2012 · External reference
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022–2023
10.1093/cid/ciaf048 · 2026 · External reference
10.3390/v18030324
10.3390/v18030324 · External reference
Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review
10.1007/s40121-024-01080-4 · 2025 · External reference
Contact with Young Children Increases the Risk of Respiratory Infection in Older Adults in Europe-the RESCEU Study
10.1093/infdis/jiab519 · 2022 · External reference
RSV Vaccines: The Past, Present and Future
10.1016/j.ijmmb.2025.100886 · 2025 · External reference
Severe Respiratory Syncytial Virus Infection in Older Adults—Burden, Clinical Outcomes and Implications for Care
2025 · External reference
Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model
10.1093/cid/ciad161 · 2023 · External reference
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
10.1093/infdis/jiad108 · 2023 · External reference
10.1001/jamapediatrics.2026.3391
10.1001/jamapediatrics.2026.3391 · External reference
Prophylactic Monoclonal Antibodies against Respiratory Syncytial Virus in Early Life: An in-Depth Review of Mechanisms of Action, Failure Factors, and Future Perspectives
10.1111/pai.70257 · 2025 · External reference
Efficacy and Safety of Respiratory Syncytial Virus Vaccines
2025 · External reference
10.1001/jamapediatrics.2026.3391
10.1001/jamapediatrics.2026.3391 · ExternalCitation · doi-reference
How Has the COVID-19 Pandemic Affected the Influenza Seasonality Patterns in Different Climate Regions?—A Time-Series Analysis
10.1002/hsr2.71456 · ExternalCitation · doi-reference
Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches
10.1002/jmv.71057 · ExternalCitation · doi-reference
High Clinical Burden of Influenza Disease in Adults Aged ≥65 Years: Can We Do Better? A Systematic Literature Review
10.1007/s12325-023-02432-1 · ExternalCitation · doi-reference
Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review
10.1007/s40121-024-01080-4 · ExternalCitation · doi-reference
Outpatient RSV Testing Rates among US Adults with Lower Respiratory Tract Disease, 2017–2024
10.1007/s40121-026-01300-z · ExternalCitation · doi-reference
A Comparative Review on the Epidemiology of Influenza, COVID-19 and Respiratory Syncytial Viruses
10.1007/s44337-025-00518-z · ExternalCitation · doi-reference
Decoding Omicron: Genetic Insight into Its Transmission Dynamics, Severity Spectrum and Ever-Evolving Strategies of Immune Escape in Comparison with Other SARS-CoV-2 Variants
10.1016/j.diagmicrobio.2025.116705 · ExternalCitation · doi-reference
Global Analysis of Influenza Epidemic Characteristics in the First Two Seasons after Lifting the Nonpharmaceutical Interventions for COVID-19
10.1016/j.ijid.2024.107372 · ExternalCitation · doi-reference
The Morbidity Spectrum of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Human Parainfluenza Virus in Young Children by Age and Country Income Level: A Systematic Review and Meta-Analysis
10.1016/j.ijid.2025.107938 · ExternalCitation · doi-reference
RSV Vaccines: The Past, Present and Future
10.1016/j.ijmmb.2025.100886 · ExternalCitation · doi-reference
Worldwide SARS-CoV-2 Omicron Variant Infection: Emerging Sub-Variants and Future Vaccination Perspectives
10.1016/j.jfma.2024.08.021 · ExternalCitation · doi-reference
Excess Mortality and Hospitalisations Associated with Respiratory Syncytial Virus, Influenza, and COVID-19 among Adults in Denmark (2015–2024): A Modelling Study
10.1016/j.lanepe.2025.101396 · ExternalCitation · doi-reference
Update on Omicron Variant and Its Threat to Vulnerable Populations
10.1016/j.puhip.2024.100494 · ExternalCitation · doi-reference
Respiratory Viruses Transmission from Children to Adults within a Household
10.1016/j.vaccine.2011.11.047 · ExternalCitation · doi-reference
Primary Care Physicians’ Perspectives on Respiratory Syncytial Virus (RSV) Disease in Adults and a Potential RSV Vaccine for Adults
10.1016/j.vaccine.2018.12.031 · ExternalCitation · doi-reference
Tracking Clinical Severity of Influenza in Adult Hospitalized Patients in 2024: Data from the FluTer Registry in Poland
10.1016/j.vaccine.2025.127443 · ExternalCitation · doi-reference
SARS-CoV-2 Omicron Is an Immune Escape Variant with an Altered Cell Entry Pathway
10.1038/s41564-022-01143-7 · ExternalCitation · doi-reference
Clinical Features and Outcomes of Viral Respiratory Infections in Adults during the 2023–2024 Winter Season
10.1038/s41598-025-19236-8 · ExternalCitation · doi-reference
Antigenic Drift and Antivaccine Shift in the 2025–2026 Influenza Season
10.1056/nejmp2600395 · ExternalCitation · doi-reference
Awareness of Respiratory Syncytial Virus and Other Respiratory Disease Vaccines among Healthcare Professionals and Their Patients in Italy: Insights from a Literature Review and a Web-Based Survey
10.1080/21645515.2025.2552557 · ExternalCitation · doi-reference
Influenza Virus: Dealing with a Drifting and Shifting Pathogen
10.1089/vim.2017.0141 · ExternalCitation · doi-reference
Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model
10.1093/cid/ciad161 · ExternalCitation · doi-reference
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022–2023
10.1093/cid/ciaf048 · ExternalCitation · doi-reference
Contact with Young Children Increases the Risk of Respiratory Infection in Older Adults in Europe-the RESCEU Study
10.1093/infdis/jiab519 · ExternalCitation · doi-reference
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
10.1093/infdis/jiad108 · ExternalCitation · doi-reference
Short-Term and Long-Term Mortality Following Hospitalized and Ambulatory Lower Respiratory Tract Illnesses among US Adults
10.1093/ofid/ofaf186 · ExternalCitation · doi-reference
The Impact of Vaccine Beliefs on the COVID-19 Vaccination among Polish Medical Staff and Students: A Cross-Sectional Study
10.1097/md.0000000000048421 · ExternalCitation · doi-reference
Prophylactic Monoclonal Antibodies against Respiratory Syncytial Virus in Early Life: An in-Depth Review of Mechanisms of Action, Failure Factors, and Future Perspectives
10.1111/pai.70257 · ExternalCitation · doi-reference
Global, Regional, and National Burden of Lower Respiratory Infections in Children: A Systematic Analysis for the Global Burden of Disease Study, 2021
10.1111/ppe.70064 · ExternalCitation · doi-reference
Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-Analysis
10.1128/jcm.01816-15 · ExternalCitation · doi-reference
High Seroprevalence and High Risk: Why Are Older Adults More Prone to Respiratory Syncytial Virus?
10.1128/jvi.01432-25 · ExternalCitation · doi-reference
The Virology of Omicron: Pathophysiology, Immune Regulation, and Clinical Impact of SARS-CoV-2 Sub Variants
10.1186/s12985-025-03020-1 · ExternalCitation · doi-reference
10.1371/journal.ppat.1014169
10.1371/journal.ppat.1014169 · ExternalCitation · doi-reference
Usefulness of RSV Rapid Diagnostic Tests in Hospitalised Children
10.15557/pimr.2024.0028 · ExternalCitation · doi-reference
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain
10.3201/eid2710.211184 · ExternalCitation · doi-reference
10.3389/fpubh.2025.1621873
10.3389/fpubh.2025.1621873 · ExternalCitation · doi-reference
10.3389/fpubh.2026.1885724
10.3389/fpubh.2026.1885724 · ExternalCitation · doi-reference
10.3390/jcm14175992
10.3390/jcm14175992 · ExternalCitation · doi-reference
10.3390/v18030324
10.3390/v18030324 · ExternalCitation · doi-reference
10.3390/vaccines13020159
10.3390/vaccines13020159 · ExternalCitation · doi-reference
10.3390/vaccines13070741
10.3390/vaccines13070741 · ExternalCitation · doi-reference
10.3390/vaccines13121234
10.3390/vaccines13121234 · ExternalCitation · doi-reference
10.3390/vaccines14080651
10.3390/vaccines14080651 · ExternalCitation · doi-reference
10.64898/2026.02.27.26347213
10.64898/2026.02.27.26347213 · ExternalCitation · doi-reference
